Epo with LFM-A13 further enhanced these effects and induced a high level of apoptosis in both of the cell lines used; however, a stronger effect was observed in triple-negative breast cancer cell line (MDA-MB-231). Here, EPO is linked to triple-negative breast carcinoma.